Overview
Charles Burdet practices in Paris, France. Mr. Burdet is rated as an Experienced expert by MediFind in the treatment of Hereditary Alpha-Tryptasemia. His top areas of expertise are COVID-19, Cerebral Hypoxia, Severe Acute Respiratory Syndrome (SARS), and Hereditary Alpha-Tryptasemia.
His clinical research consists of co-authoring 80 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hereditary Alpha-Tryptasemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Mr. Burdet isAdvanced. Learn about COVID-19.
- Experienced
- Cerebral HypoxiaMr. Burdet isExperienced. Learn about Cerebral Hypoxia.
- Febrile NeutropeniaMr. Burdet isExperienced. Learn about Febrile Neutropenia.
- Hereditary Alpha-TryptasemiaMr. Burdet isExperienced. Learn about Hereditary Alpha-Tryptasemia.
- HIV/AIDSMr. Burdet isExperienced. Learn about HIV/AIDS.
- Interstitial NephritisMr. Burdet isExperienced. Learn about Interstitial Nephritis.
- Mast Cell Activation Syndrome (MCAS)Mr. Burdet isExperienced. Learn about Mast Cell Activation Syndrome (MCAS).